Serono Serostim Counterfeits May Have Originated In Asia, FDA Says
Executive Summary
Counterfeit versions of Serono's Serostim recently found in the U.S. may have originated in Asia, FDA Senior Associate Commissioner for Policy, Planning & Legislation William Hubbard told the Senate Commerce/Consumer Affairs Subcommittee Sept. 5.
You may also be interested in...
Rx Reimportation Bill In Senate Will Focus On Canada, Sen. Dorgan Says
Prescription drug reimportation advocates in the Senate are focusing on a Canada-only approach for 2001.
Rx Reimportation Bill In Senate Will Focus On Canada, Sen. Dorgan Says
Prescription drug reimportation advocates in the Senate are focusing on a Canada-only approach for 2001.
Serono Serostim
Counterfeit Serostim has been reported by 10 to 12 patients, primarily in California. The only reported adverse reaction by patients who had injected the counterfeit product was skin irritation at the injection site, the company said. FDA's Office of Criminal Investigations is attempting to determine the distributor of the fake product. Somatropin is approved for AIDS wasting